AI assistant
Sending…
GENTEX CORP — Director's Dealing 2019
Jul 24, 2019
30893_dirs_2019-07-24_c5daef54-5855-4764-96b3-8d8ecbc6bbfa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2019-07-24
Reporting Person: Chiodo Matthew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-24 | Common Stock | M | 3060.00 | $18.30 | Acquired | 30776.00 | Direct |
| 2019-07-24 | Common Stock | M | 2500.00 | $15.69 | Acquired | 33276.00 | Direct |
| 2019-07-24 | Common Stock | S | 5560.00 | $27.0682 | Disposed | 27716.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-24 | Employee Stock Option (Right to buy) | $18.30 | M | 3060.00 | Disposed | 2020-03-31 | Common Stock (3060.00) | Direct |
| 2019-07-24 | Employee Stock Option (Right to buy) | $15.69 | M | 2500.00 | Disposed | 2021-03-31 | Common Stock (2500.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $27.05 to $27.075. The price reported above reflects the weighted average price.
F2: Options are fully vested.
F3: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.
More from GENTEX CORP
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19